Namita Thapar, a Shark Tank India investor, is poised to make a substantial profit from the upcoming initial public offering (IPO) of Emcure Pharmaceuticals. Thapar, known as 'Phar-Maa' on the show, is set to offload a portion of her stake in the company, potentially reaping a return of 293 times her initial investment. Several other promoters, including Satish Ramanlal Mehta and Pushpa Rajnikant Mehta, will also be selling shares in the IPO, with potential returns exceeding 10,000 times their original investments.